Anbio Biotechnology Class...

NASDAQ: NNNN · Real-Time Price · USD
50.14
1.58 (3.25%)
At close: Aug 14, 2025, 3:59 PM
49.61
-1.06%
Pre-market: Aug 15, 2025, 06:58 AM EDT

Anbio Biotechnology Class A Ordinary Shares Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
8.19M 6.71M 23.54M 4.43M
Cost of Revenue
2.3M 3.35M 10.98M 1.89M
Gross Profit
5.89M 3.36M 12.56M 2.54M
Operating Income
2M 1.96M 10.2M 2.46M
Interest Income
337.51K 165.34K 42.24K n/a
Pretax Income
2.37M 2.25M 10.01M 2.54M
Net Income
2.37M 2.25M 10.01M 2.54M
Selling & General & Admin
3.44M 1.27M 2.17M 86.09K
Research & Development
454.23K 134.7K 200K n/a
Other Expenses
n/a n/a n/a n/a
Operating Expenses
3.89M 1.4M 2.37M 86.09K
Interest Expense
n/a n/a 8K n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
6.19M 4.75M 13.35M 1.97M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
42.29M 143.89M 143.89M 100M
Shares Outstanding (Diluted)
42.29M 187.78M 143.89M 100M
EPS (Basic)
0.06 0.02 0.07 0.03
EPS (Diluted)
0.06 0.01 0.07 0.03
EBITDA
2.57M 2.45M 10.03M 2.54M
EBIT
2.37M 2.25M 10.02M 2.54M
Depreciation & Amortization
n/a 13.04K 6.25K n/a